Valeo Financial Advisors’s Boston Scientific BSX Stock Holding History

Valeo Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,500	Closed	-$134K	–	704
2024 Q4	$134K	Hold	1,500	–	–	﹤0.01%	685
2024 Q3	$126K	Hold	1,500	–	–	﹤0.01%	670
2024 Q2	$116	Sell	1,500 -1,500	-50%	-$110K	﹤0.01%	671
2024 Q1	$218	Hold	3,000	–	–	﹤0.01%	654
2023 Q4	$174	Hold	3,000	–	–	﹤0.01%	645
2023 Q3	$158	Buy	+3,000	New	+$157K	﹤0.01%	631

Other funds holding BSX

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

NPPM

North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

QPBE

Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return

Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Valeo Financial Advisors's BSX Position: Q3 2026 in Review

Valeo Financial Advisors increased its Boston Scientific (BSX) stake by 0.01% in Q3 2026, buying an estimated $46 and bringing the position to 10,536 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #481.

Valeo Financial Advisors first reported a position in BSX in Q3 2017 and has held it in 36 quarters since. The position peaked at $2.42M in Q2 2025. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Valeo Financial Advisors held 10,536 shares of Boston Scientific worth $460K as of Q3 2026.
Valeo Financial Advisors bought 1 Boston Scientific share in Q3 2026, an estimated $46.
Boston Scientific made up 0.01% of Valeo Financial Advisors's portfolio in Q3 2026, its #481 holding.
Valeo Financial Advisors first reported a position in Boston Scientific in Q3 2017 and has held it in 36 quarters since.
Valeo Financial Advisors's Boston Scientific position peaked at $2.42M in Q2 2025.
43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.